5492
M. Movassaghi et al. / Tetrahedron Letters 50 (2009) 5489–5492
4915; (f) McMorris, T. C.; Staake, M. D.; Kelner, M. J. Org. Chem. 2004, 69, 619;
(g) Gong, J.; Neels, J. F.; Yu, X.; Kensler, T. W.; Peterson, L. A.; Sturla, S. J. J. Med.
Chem. 2006, 49, 2593.
C). This strategy provides ready access to the synthesis of various
functionalized precursors to the core warheads of the illudin anti-
tumor natural products. The evaluation of these fused bicycles in
the synthesis of illudin derivatives and their respective biological
evaluation will be reported in due course.
6. Movassaghi, M.; Piizzi, G.; Siegel, D. S.; Piersanti, G. Angew. Chem., Int. Ed. 2006,
45, 5859.
7. For representative examples, see: (a) Kim, S.-H.; Bowden, N.; Grubbs, R. H. J.
Am. Chem. Soc. 1994, 116, 10801; (b) Zuercher, W. J.; Scholl, M.; Grubbs, R. H. J.
Org. Chem. 1998, 63, 4291; (c) Layton, M. E.; Morales, C. A.; Shair, M. D. J. Am.
Chem. Soc. 2002, 124, 773; (d) Fukumoto, H.; Takanishi, K.; Ishihara, J.;
Hatakeyama, S. Angew. Chem., Int. Ed. 2006, 45, 2731; For a review, see: (e)
Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chem., Int. Ed. 2005, 44, 4490.
8. (a) Miller, S. J.; Blackwell, H. E.; Grubbs, R. H. J. Am. Chem. Soc. 1996, 118, 9606;
(b) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953.
9. The allylcarbonate fragmentation may involve a competing pathway in which
Acknowledgments
M.M. is an Alfred P. Sloan Research Fellow, a Beckman Young
Investigator, and a Camille Dreyfus Teacher-Scholar. We thank Jus-
tin Kim and Dr. Peter Müller for assistance with X-ray crystallo-
graphic analysis. We acknowledge financial support in part by
NIH-NIGMS (GM074825) and Amgen.
catalyst decomposition products may form
p-allyl complexes. For an example
of ruthenium -allyl complex formation with allylcarbonates, see: Gürbüz, N.;
p
Özdemir, I.; Çetinkaya, B.; Renaud, J.-L.; Demerseman, B.; Bruneau, C.
Tetrahedron Lett. 2006, 47, 535.
10. For representative examples of allyldialkylsilicon tether mediated olefin
metathesis, see: (a) Chang, S.; Grubbs, R. H. Tetrahedron Lett. 1997, 38, 4757;
(b) Yao, Q. Org. Lett. 2001, 3, 2069.
11. For examples of metathesis reactions using allyloxysilane tethers, see: (a)
Hoye, T. R.; Promo, M. A. Tetrahedron Lett. 1999, 40, 1429; (b) Briot, A.; Bujard,
M.; Gouverneur, V.; Nolan, S. P.; Mioskowski, C. Org. Lett. 2000, 2, 1517; (c) Van
de Weghe, P.; Aoun, J.-G.; Boiteau, D.; Eustache, J. Org. Lett. 2002, 4, 4105; (d)
Postema, M. H.; Piper, J. L. Tetrahedron Lett. 2002, 43, 7095; (e) Evans, P. E.; Cui,
J.; Gharpure, S. J.; Polosukhin, A.; Zhang, H.-R. J. Am. Chem. Soc. 2003, 125,
14702.
References and notes
1. (a) Anchel, M.; Hervey, A.; Robbins, W. J. Proc. Natl. Acad. Sci. U.S.A. 1952, 38,
927; (b) McMorris, T. C.; Anchel, M. J. Am. Chem. Soc. 1965, 87, 1594.
2. (a) Kelner, M. J.; McMorris, T. C.; Taetle, R. J. Natl. Cancer Inst. 1990, 82, 1562; (b)
McMorris, T. C.; Kelner, M. J.; Chadha, R. K.; Siegel, J. S.; Moon, S.; Moya, M. M.
Tetrahedron 1989, 45, 5433; (c) Gong, J.; Vaidyanathan, V. G.; Yu, X.; Kensler, T.
W.; Peterson, L. A.; Sturla, S. J. J. Am. Chem. Soc. 2007, 129, 2101; (d) Neels, J. F.;
Gong, J.; Yu, X.; Sturla, S. J. Chem. Res. Toxicol. 2007, 20, 1513.
3. McMorris, T. C.; Kelner, M. J.; Wang, W.; Yu, J.; Estes, L. A.; Taetle, R. J. Nat. Prod.
1996, 59, 896.
12. Zefirov, N. S.; Kuznetsova, T. S.; Kozhushkov, S. I.; Surmina, L. S.; Rashchupkina,
Z. A. Zh. Org. Khim. 1983, 19, 541.
4. (a) Alexandre, J.; Raymond, E.; Kaci, M. O.; Brian, E. C.; Lokiec, F.; Kahatt, C.;
Faivre, S.; Yovine, A.; Goldwasser, F.; Smith, S. L.; MacDonald, J. R.; Misset, J.-L.;
Cvitkovic, E. Clin. Cancer Res. 2004, 10, 3377; (b) Yeo, W.; Boyer, M.; Chung, H.
C.; Ong, S. Y. K.; Lim, R.; Zee, B.; Ma, B.; Lam, K. C.; Mo, F. K. F.; Ng, E. K. W.; Ho,
R.; Clarke, S.; Roh, J. K.; Beale, P.; Rha, S. Y.; Jeung, H. C.; Soo, R.; Goh, B. C.; Chan,
A. T. C. Cancer Chemother. Pharmacol. 2007, 59, 295; (c) Wiltshire, T.; Senft, J.;
Wang, Y.; Konat, G. W.; Wenger, S. L.; Reed, E.; Wang, W. Mol. Pharmacol. 2007,
71, 1051; (d) Kelner, M. J.; McMorris, T. C.; Rojas, R. J.; Estes, L. A.;
Suthipinijtham, P. Cancer Chemother. Pharmacol. 2008, 63, 19; (e) Dings, R. P.
M.; Van Laar, E. S.; Webber, J.; Zhang, Y.; Griffin, R. J.; Waters, S. J.; MacDonald,
J. R.; Mayo, K. H. Cancer Lett. 2008, 265, 270.
5. For total syntheses of illudin M and S, see: (a) Matsumoto, T.; Shirahama, H.;
Ichihara, A.; Shin, H.; Kagawa, S.; Sakan, F.; Matsumoto, S.; Nishida, S. J. Am.
Chem. Soc. 1968, 90, 3280; (b) Matsumoto, T.; Shirahama, H.; Ichihara, A.; Shin,
H.; Kagawa, S.; Sakan, F.; Miyano, K. Tetrahedron Lett. 1971, 2049; (c) Kinder, F.
R.; Bair, K. W. J. Org. Chem. 1994, 59, 6965; For total syntheses of Acylfulvene
and Irofulven, see: (d) McMorris, T. C.; Hu, Y.; Yu, J.; Kelner, M. Chem. Commun.
1997, 315; (e) Brummond, K. M.; Lu, J.; Petersen, J. J. Am. Chem. Soc. 2000, 122,
13. (a) Bandini, M.; Cozzi, P. G.; Melchiorre, P.; Umani-Ronchi, A. Tetrahedron Lett.
2001, 42, 3041; (b) Bandini, M.; Cozzi, P. G.; Garelli, A.; Melchiorre, P.; Umani-
Ronchi, A. Eur. J. Org. Chem. 2002, 3243.
14. The alkynes 15b and 15c were prepared according to literature procedures.
15b: Van Boom, J. H.; Brandsma, L.; Arens, J. F. Rec. Tr. Chim. Pays-Bas 1966, 85,
952. 15c: Apparu, M.; Barrelle, M. Bull. Soc. Chim. Fr. 1983, 83. 15d: Treatment
of corresponding propargyl alcohol with PMBCl.
15. For clarity only the major diastereomer is shown.
16. On larger scale, 18a could be isolated in 76% yield using optimized EYRCM
conditions.
17. It may also be plausible that the formation of product 20 occurs through initial
complexation of the metathesis catalyst with the alkyne followed by EYRCM.
18. Diethylallyloxysilylchloride was prepared according to: Krolevets, A. A.;
Antipova, V. V.; Popov, A. G.; Adamov, A. V. Zh. Obsch. Khim. 1988, 58, 2274.
19. The crystal structure of the corresponding bis-p-nitrobenzoate derivative of
29d has been deposited at the Cambridge Crystallographic Data Center, please
see: CCDC# 735275.